Assertio (ASRT)
(Delayed Data from NSDQ)
$1.00 USD
0.00 (0.00%)
Updated May 28, 2024 04:00 PM ET
After-Market: $1.01 +0.01 (1.00%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth F Momentum B VGM
Price, Consensus and EPS Surprise
ASRT 1.00 0.00(0.00%)
Will ASRT be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ASRT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ASRT
Assertio (ASRT) Stock Plunges 65% in 3 Months: Here's Why
Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO
ASRT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is the Options Market Predicting a Spike in Assertio (ASRT) Stock?
Is the Options Market Predicting a Spike in Assertio (ASRT) Stock?
Assertio (ASRT) Q2 Earnings Miss Estimates
Other News for ASRT
Assertio Holdings initiated with bullish view at Alliance Global Partners, here's why
Assertio to Participate in Benchmark Healthcare Conference on May 21-22
BUXTON HELMSLEY RELEASES LETTER FROM CERTIFIED FRAUD EXAMINER ATTESTING TO DISCLOSURE FAILURES AND DEFICIENCIES BY ASSERTIO HOLDINGS BOARD OF DIRECTORS
Assertio Holdings holder Buxton Helmsley releases letter from fraud examiner
Assertio to Participate in AGP Healthcare Conference on May 21